Clinical trial · Observational
STI Knowledge and HPV Vaccine Acceptance in Bamako, Mali in 2012
Knowledge, Attitudes, Practices and Willingness to Vaccinate in Preparation for the Introduction of HPV Vaccines in Bamako, Mali
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Although screening for pre-cancerous cervical lesions and human papilloma virus (HPV) vaccination are accepted and effective means to prevent cervical cancer, women in Mali have limited access to these interventions. In addition, cervical cancer prevention by HPV vaccination has been controversial in some settings. To reduce cervical cancer prevalence and increase HPV vaccine uptake, it is important to understand the level of knowledge about cervical cancer screening and practices related to vaccination in at-risk populations. In this study, the level of knowledge about HPV and cervical cancer and attitudes towards vaccination were assessed among 301 participants (male and female, adults and adolescents) in a house-to-house survey in two urban neighborhoods in Bamako, Mali. The survey was combined with a brief educational session on HPV. Prior to the education session, overall knowledge of HPV infection and cervical cancer was very low: only 8% knew that HPV is a sexually transmitted infection (STI). Less than 20% of women had ever consulted a gynecologist and less than 3% had ever had cervical cancer screening. After hearing a description of HPV vaccine, more than 80% would accept HPV vaccination; fathers and husbands were identified as primary decisions makers and local clinics or the home as preferred sites for vaccination. This study provides information on STI knowledge and vaccine acceptance in Bamako, Mali in 2012, prior to the introduction of HPV vaccination.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| HPV | — | UNRESOLVED | — |
| HPV-Related Cervical Carcinoma | Human Papillomavirus-Related Cervical Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| HPV Vaccine Acceptance Survey | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Bamako Participants
- description
- 301 male and female participants. Teenagers and adults. Living in two urban regions of Bamako.
- interventionNames
- Behavioral: HPV Vaccine Acceptance Survey
Primary outcomes (1)
- measure
- Participants' acceptance of the vaccine
- timeFrame
- immediately after the intervention
- description
- Number of participants willing to be vaccinated against HPV and their vaccination preferences after educational sessions
Secondary outcomes (1)
- measure
- Knowledge of STIs, HPV, and Cervical Cancer
- timeFrame
- immediately after the intervention
- description
- Knowledge Question asked before and after educational session
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 12 Years
Show eligibility criteria text
Inclusion Criteria: * 12-17 years of age, with guardian consent * 18 years or older * Male or Female * Living in Mèkin-Sikoro and Djikoroni Exclusion Criteria: * 12-17 years of age, without guardian consent * \<12 years of age * Living outside Mèkin-Sikoro and Djikoroni
References
Publications (0)
Data not yet available